Treatment Adoption
40% Faster with Targeted
Scientific Outreach

Veeva Pulse Field Trends Report

As the pharmaceutical industry continues to adapt to HCP preferences and hybrid commercial models, it’s critical to stay on top of evolving field and HCP engagement trends.

Each quarter, the Veeva Pulse Field Trends Report provides unique insights into global and regional engagement trends based on an analysis of 600 million HCP interactions across more than 80% of biopharmas worldwide.

Want to dive deeper?
Below are some of the top insights from previous Veeva Pulse Field Trends Reports. You can also access the full reports for comprehensive data and analysis.

Pre-launch Scientific Outreach Accelerates Treatment Adoption by 40%

Prioritizing investments in targeted scientific activities with the right experts sets the stage for faster treatment adoption and, ultimately, commercial success at launch and beyond.

HCP Access Declined from 60% to 45%

Access is back to pre-pandemic levels and HCPs remain highly selective – about half limit access to three or fewer biopharmas. But connected engagement across sales, marketing, and medical is giving HCPs what they need, when they need it.

3 Ways Biopharmas Are Using Field Insights to Better Engage HCPs

Learn how Kyowa Kirin, Lundbeck, and Boehringer Ingelheim turn Veeva Pulse insights into action to empower field teams with content, engagement opportunities, and channels to build strong customer relationships that create lasting value for HCPs and patients.

Achieve customer centricity across sales, marketing, and medical

Help your field teams engage HCPs at the right time with the right omnichannel mix.